Skip to content
Screener

Guardant Health GH Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$301.7MBeat by $22.5M
EPS-$0.85Miss by $0.38
Revenue estimate$279.2M
EPS estimate-$0.47

Next report

Oct 28, 2026 (in 2 months)
Revenue estimate$350.1M
EPS estimate-$0.28

Financials

Q1 2026

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$12.12B+130%
Enterprise value$12.72B+121%
P/S11.2×+4.4×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Current ratio4.7×+0.6×

Segments

By product

See full
Oncology$205.0M+36.1%
Biopharma and data$53.0M+16.8%
Screening$41.6M+633%
Licensing and other$2.1M+15.3%

By segment

See full
Reportable Segment$301.7M+48.3%

FAQ

When did Guardant Health report Q1 2026 earnings?
Guardant Health (GH) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Guardant Health's Q1 2026 revenue and EPS?
Guardant Health reported revenue of $301.7M and eps of $-0.85 for Q1 2026.
Did Guardant Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $279.2M by $22.5M. EPS missed the consensus estimate of $-0.47 by $0.38.
How did Guardant Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.3% from $203.5M a year earlier and eps declined 73.5% from $-0.49.
Where can I find Guardant Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001576280-26-000024) and the 10-Q periodic report (0001576280-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.